Biggest News Aggregation in the World
📰 Overactive Bladder News

Page 170 - Overactive Bladder News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Overactive Bladder. Real-time updates on events, politics, business and more.

Urovant Sciences, Inc.: Urovant Sciences to Present New Ambulatory Blood Pressure Data in Patients Dosed With GEMTESA (vibegron) 75 mg for Overactive Bladder at the 2021 Annual Meeting of the American Urological Association

Data from the dedicated, stand-alone, ambulatory blood pressure trial will be the focus of a podium presentation Efficacy in patients with 'dry' overactive bladder, based on a post-hoc analysis
New York United States City Of United Kingdom Sumitomo Dainippon Pharma Marco Polo

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Alpha Cognition Inc.: Alpha Cognition Appoints Lauren D'Angelo as Chief Commercial Officer to Drive Strategic Growth

(1) Vancouver, British Columbia--(Newsfile Corp. - May 4, 2021) - Alpha Cognition Inc. (TSXV: ACOG) ("Alpha Cognition", or the "Company"), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, is pleased to announce the appointment of Lauren DAngelo to Chief Commercial Officer. In this role, she will ensure the integrated commercial success of the company. Her initial focus will be ...
City Of United Kingdom British Columbia Michael Mcfadden Kostenloser Wertpapierhandel Stefan Eftychiou

Alpha Cognition Appoints Lauren D'Angelo as Chief Commercial Officer

Vancouver, British Columbia–(Newsfile Corp. – May 4, 2021) – Alpha Cognition Inc. (TSXV: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, is pleased to announce the appointment of Lauren D’Angelo to Chief Commercial Officer. In this role, she will ensure the integrated commercial success of the company. Her initial fo...
City Of United Kingdom British Columbia Michael Mcfadden Stefan Eftychiou Lauren Dangelo

App-based treatment for urinary incontinence was as effective as in-person treatment

App-based treatment for urinary incontinence was as effective as in-person treatment A mobile app designed to help women manage urinary incontinence was as effective as usual, in-person treatment of incontinence in primary care, according to new research from the Netherlands. The study included 262 women with frequent stress incontinence, overactive bladder or a mix of symptoms. Participants were randomly assigned to use a standalone mobile app called URinControl, which offered pelvic floor mus...
United States Annemm Loohuis Joel Heidelbaugh Emily Henderson University Medical Centre Groningen University Of Groningen

World Market Outlook for the Overactive Bladder Treatment Market to 2028 and the Economic Impact of COVID-19

Dublin, March 09, 2021 (GLOBE NEWSWIRE) -- The "Overactive Bladder Treatment Market Research and Outlook, 2020 - Trends, Growth Opportunities and Forecasts to 2028" report has been added to ResearchAndMarkets.com's offering. This report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Overactive Bladder Treatment market types and applications. It is a focused study on the Overactive Bladder Treatment mar...
Overactive Bladder Segmentation Analysis Economic Impact Analysis பொருளாதார தாக்கம் பகுப்பாய்வு
Source: yahoo.com

Allergan Aesthetics and Allergan, an AbbVie Company, to Present 16 Neurotoxin Research Abstracts Across Multiple Therapeutic and Cosmetic Indications at the TOXINS 2021 Virtual Conference

Allergan Aesthetics and Allergan, an AbbVie Company, to Present 16 Neurotoxin Research Abstracts Across Multiple Therapeutic and Cosmetic Indications at the TOXINS 2021 Virtual Conference - BOTOX® (onabotulinumtoxinA) and BOTOX Cosmetic® clinical data across multiple therapeutic and aesthetic indications - New analyses from CD-PROBE study evaluating sustained efficacy and tolerability of onabotulinumtoxinA in patients with cervical dystonia - New analyses from the ASPIRE study on patient adhe...
United Kingdom Rheinland Pfalz United States Lou Gehrig International Neurotoxin Association Foundational Neuroscience Center

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science